Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 796
Filter
Add filters

Year range
3.
Prim Care Companion CNS Disord ; 22(4)2020 Jul 16.
Article in English | MEDLINE | ID: covidwho-654929

ABSTRACT

The Psychiatric Consultation Service at Massachusetts General Hospital sees medical and surgical inpatients with comorbid psychiatric symptoms and conditions. During their twice-weekly rounds, Dr Stern and other members of the Consultation Service discuss diagnosis and management of hospitalized patients with complex medical or surgical problems who also demonstrate psychiatric symptoms or conditions. These discussions have given rise to rounds reports that will prove useful for clinicians practicing at the interface of medicine and psychiatry.


Subject(s)
Coronavirus Infections/therapy , Deprescriptions , Dexmedetomidine/therapeutic use , Emergence Delirium/diagnosis , Hypnotics and Sedatives/therapeutic use , Pneumonia, Viral/therapy , Respiration, Artificial/methods , Substance Withdrawal Syndrome/diagnosis , Adult , Analgesics, Opioid/therapeutic use , Benzodiazepines/therapeutic use , Betacoronavirus , Emergence Delirium/therapy , Humans , Male , Neurologic Examination , Pandemics , Practice Guidelines as Topic , Propofol/therapeutic use , Substance Withdrawal Syndrome/therapy
4.
Medwave ; 20(4): e7916, 2020 Jun 01.
Article in Spanish | MEDLINE | ID: covidwho-651724

ABSTRACT

Introduction: COVID-19 is a world public health problem due to its morbidity and mortality, especially in at-risk groups. The dental environment has a high risk of viral transmission; accordingly, this study aimed to identify recommendations based on the best available evidence for dental care during this pandemic. Methods: We performed a search for scientific evidence published since 2002 to March 23th 2020 in electronic databases (MEDLINE/PubMed, EMBASE, Cochrane, and Epistemonikos) and the web pages of the American Dental Association, Centers for Disease Control and Prevention Oral Health, the Ministry of Health in Chile and scientific societies. Results: We included nine published studies. The recommendations were the following: unrestricted use of personal protection elements, use of extraoral radiographic techniques, use of mouth rinses with 1% hydrogen peroxide or 0.2% iodine povidone, a four-hand technique with ongoing aspiration and the use of absorbable sutures. Furthermore, there is a consensus that non-urgent treatments should be postponed during periods of community transmission. Conclusions: Dental practitioners are exposed to a high risk of cross-infection, meaning they must implement recommendations based on the best available evidence to preserve the health of team members and the population they are caring for.


Subject(s)
Coronavirus Infections/prevention & control , Coronavirus Infections/transmission , Dental Care/standards , Infectious Disease Transmission, Patient-to-Professional/prevention & control , Infectious Disease Transmission, Professional-to-Patient/prevention & control , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Pneumonia, Viral/transmission , Humans , Practice Guidelines as Topic
8.
Zhong Nan Da Xue Xue Bao Yi Xue Ban ; 45(5): 513-517, 2020 May 28.
Article in English, Chinese | MEDLINE | ID: covidwho-745334

ABSTRACT

Coronavirus disease 2019 (COVID-19) is an acute respiratory infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with COVID-19 may have respiratory dysfunction, physical dysfunction, and psychological dysfunction. Rehabilitation and long-term follow-up management are particularly important for these patients. Traditional face-to-face rehabilitation possesses high risk of infection, low coverage, time-consuming and laborious. While online rehabilitation nursing mode will be more feasible by using mobile internet technology. Based on literature review and focus group discussion, we standardize the internet-based nursing assessment, plan formulation, implementation, and effectiveness evaluation on discharged patients with COVID-19.We hope it can give guidance for nurses to provide better care for patients.


Subject(s)
Coronavirus Infections/nursing , Coronavirus Infections/rehabilitation , Internet-Based Intervention , Pneumonia, Viral/nursing , Pneumonia, Viral/rehabilitation , Betacoronavirus , Humans , Pandemics , Practice Guidelines as Topic
9.
Zhong Nan Da Xue Xue Bao Yi Xue Ban ; 45(5): 598-602, 2020 May 28.
Article in English, Chinese | MEDLINE | ID: covidwho-745317

ABSTRACT

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the outbreak of coronavirus disease 2019 in Wuhan City, China. The SARS-CoV-2 is genetically similar to the coronavirus derived from bat. The SARS-CoV-2, the SARS-CoV and the Middle East respiratory syndrome coronavirus (MERS-CoV) all belong to beta coronavirus. Since the outbreak of the coronavirus disease 2019, effective antiviral drugs have become a hot issue in the world. Very little about SARS-CoV-2 is known and there is no precedent for treatment. The National Health Commission has repeatedly revised the diagnosis and treatment guide for the coronavirus disease 2019. The latest guide is "New Coronary Virus-Infected Pneumonia Diagnosis and Treatment Plan (Seventh Trial Version)"(short for Seventh Version of Diagnosis and Treatment Plan). But the use of antiviral drugs is still on trial and no rigorous clinical trials data is available. Hot anti-SARS-CoV-2 drugs include interferon α, ribavirin, lopinavir/ritonavir, chloroquine phosphate, abidol, as well as hydroxychloroquine sulfate and remdesivir. But the later 2 drugs aren't mentioned in the Seventh Version of Diagnosis and Treatment Plan.


Subject(s)
Antiviral Agents/therapeutic use , Coronavirus Infections/drug therapy , Pneumonia, Viral/drug therapy , Betacoronavirus , China , Humans , Pandemics , Practice Guidelines as Topic
10.
Zhong Nan Da Xue Xue Bao Yi Xue Ban ; 45(5): 518-524, 2020 May 28.
Article in English, Chinese | MEDLINE | ID: covidwho-745311

ABSTRACT

According to the fact that many coronavirus disease 2019 (COVID-19) patients are seeking for medical help due to some other possible clinical symptoms, besides respiratory symptoms, all the internal medicine departments (including emergency department) could be involved. Moreover, an increasing number of physician are going to work in fever clinic, isolation wards and supporting the medical work in Hubei Province in the future. For a better medical work implementation of physician against COVID-19 and the interpretation of this viral transmission, the work guide was drawn up by Hunan Medical Association, Internal Medicine Specialized Committee.


Subject(s)
Coronavirus Infections/epidemiology , Physicians , Pneumonia, Viral/epidemiology , Practice Guidelines as Topic , Betacoronavirus , China , Humans , Internal Medicine/organization & administration , Pandemics
11.
J Med Internet Res ; 22(6): e20239, 2020 06 10.
Article in English | MEDLINE | ID: covidwho-742634

ABSTRACT

BACKGROUND: The coronavirus disease (COVID-19) was discovered in China in December 2019. It has developed into a threatening international public health emergency. With the exception of China, the number of cases continues to increase worldwide. A number of studies about disease diagnosis and treatment have been carried out, and many clinically proven effective results have been achieved. Although information technology can improve the transferring of such knowledge to clinical practice rapidly, data interoperability is still a challenge due to the heterogeneous nature of hospital information systems. This issue becomes even more serious if the knowledge for diagnosis and treatment is updated rapidly as is the case for COVID-19. An open, semantic-sharing, and collaborative-information modeling framework is needed to rapidly develop a shared data model for exchanging data among systems. openEHR is such a framework and is supported by many open software packages that help to promote information sharing and interoperability. OBJECTIVE: This study aims to develop a shared data model based on the openEHR modeling approach to improve the interoperability among systems for the diagnosis and treatment of COVID-19. METHODS: The latest Guideline of COVID-19 Diagnosis and Treatment in China was selected as the knowledge source for modeling. First, the guideline was analyzed and the data items used for diagnosis and treatment, and management were extracted. Second, the data items were classified and further organized into domain concepts with a mind map. Third, searching was executed in the international openEHR Clinical Knowledge Manager (CKM) to find the existing archetypes that could represent the concepts. New archetypes were developed for those concepts that could not be found. Fourth, these archetypes were further organized into a template using Ocean Template Editor. Fifth, a test case of data exchanging between the clinical data repository and clinical decision support system based on the template was conducted to verify the feasibility of the study. RESULTS: A total of 203 data items were extracted from the guideline in China, and 16 domain concepts (16 leaf nodes in the mind map) were organized. There were 22 archetypes used to develop the template for all data items extracted from the guideline. All of them could be found in the CKM and reused directly. The archetypes and templates were reviewed and finally released in a public project within the CKM. The test case showed that the template can facilitate the data exchange and meet the requirements of decision support. CONCLUSIONS: This study has developed the openEHR template for COVID-19 based on the latest guideline from China using openEHR modeling methodology. It represented the capability of the methodology for rapidly modeling and sharing knowledge through reusing the existing archetypes, which is especially useful in a new and fast-changing area such as with COVID-19.


Subject(s)
Coronavirus Infections , Electronic Health Records/standards , Pandemics , Pneumonia, Viral , Practice Guidelines as Topic , China/epidemiology , Coronavirus Infections/epidemiology , Decision Support Systems, Clinical , Humans , Pneumonia, Viral/epidemiology
14.
Z Rheumatol ; 79(7): 686-691, 2020 Sep.
Article in German | MEDLINE | ID: covidwho-738390

ABSTRACT

The recommendations of the German Society of Rheumatology (DGRh) update, which update and expand the guidance on the management of patients with inflammatory rheumatic diseases in view of SARS-CoV­2 created at the beginning of the COVID-19 pandemic, correspond in many points with the recommendations for action of the American (ACR) and European (EULAR) societies, but also differ in some points. Therefore, this article discusses the core recommendations of the DGRh update on the prevention of SARS-CoV-2/COVID-19, the risk assessment for inflammatory rheumatic diseases and the use of antirheumatic treatments in the context and in comparison to the ACR and EULAR recommendations, and provides an overview of the risk assessment of individual antirheumatic drugs.


Subject(s)
Antirheumatic Agents/therapeutic use , Coronavirus Infections/epidemiology , Inflammation/therapy , Pneumonia, Viral/epidemiology , Rheumatic Diseases/therapy , Rheumatology , Betacoronavirus , Europe , Germany , Humans , Pandemics , Practice Guidelines as Topic , Risk Assessment , Societies, Medical , United States
18.
Z Rheumatol ; 79(7): 686-691, 2020 Sep.
Article in German | MEDLINE | ID: covidwho-734832

ABSTRACT

The recommendations of the German Society of Rheumatology (DGRh) update, which update and expand the guidance on the management of patients with inflammatory rheumatic diseases in view of SARS-CoV­2 created at the beginning of the COVID-19 pandemic, correspond in many points with the recommendations for action of the American (ACR) and European (EULAR) societies, but also differ in some points. Therefore, this article discusses the core recommendations of the DGRh update on the prevention of SARS-CoV-2/COVID-19, the risk assessment for inflammatory rheumatic diseases and the use of antirheumatic treatments in the context and in comparison to the ACR and EULAR recommendations, and provides an overview of the risk assessment of individual antirheumatic drugs.


Subject(s)
Antirheumatic Agents/therapeutic use , Coronavirus Infections/epidemiology , Inflammation/therapy , Pneumonia, Viral/epidemiology , Rheumatic Diseases/therapy , Rheumatology , Betacoronavirus , Europe , Germany , Humans , Pandemics , Practice Guidelines as Topic , Risk Assessment , Societies, Medical , United States
19.
J Contin Educ Nurs ; 51(9): 402-411, 2020 Sep 01.
Article in English | MEDLINE | ID: covidwho-729674

ABSTRACT

This article provides the most current guidelines for nurse educators and nurses to use systems thinking to manage COVID-19 in health systems. A working definition of systems thinking is offered, with a review of basic knowledge and care in the context of the system awareness model (SAM). Seven key messages assist nurse educators and nurses in the management of COVID-19 patients culminating in leadership of complex health care systems using systems thinking. [J Contin Educ Nurs. 2020;51(9):402-411.].


Subject(s)
Coronavirus Infections/therapy , Critical Care Nursing/education , Critical Care Nursing/standards , Delivery of Health Care/organization & administration , Delivery of Health Care/statistics & numerical data , Health Personnel/education , Pneumonia, Viral/therapy , Practice Guidelines as Topic , Adult , Betacoronavirus , Curriculum , Education, Nursing, Continuing/organization & administration , Female , Humans , Male , Middle Aged , Pandemics , Systems Analysis
20.
J Contin Educ Nurs ; 51(9): 399-401, 2020 Sep 01.
Article in English | MEDLINE | ID: covidwho-729673

ABSTRACT

In light of the COVID-19 pandemic and uncertainties around risk of transmission, urgent hospital resuscitation (also known as "Code Blue") efforts are needed, pivoting to protect health care workers. This article provides teaching tips for "Protected Code Blues." [J Contin Educ Nurs. 2020;51(9):399-401.].


Subject(s)
Cardiopulmonary Resuscitation/education , Cardiopulmonary Resuscitation/nursing , Cardiopulmonary Resuscitation/standards , Coronavirus Infections/nursing , Health Personnel/education , Nursing Staff, Hospital/education , Pneumonia, Viral/nursing , Simulation Training/organization & administration , Adult , Betacoronavirus , Curriculum , Education, Nursing, Continuing/organization & administration , Female , Humans , Male , Middle Aged , Pandemics , Practice Guidelines as Topic
SELECTION OF CITATIONS
SEARCH DETAIL